DrugDev Launches CRO Program with INC Research

Article

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research.

DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research. Sponsors will be offered use of DrugDevs Golden Number, used to match and master data from disparate sources, and the new DrugDev patient engagment solution, which enables sites to send information, documents and notifications to patients via SMS.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.